Anti-TMPRSS3 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the cytoplasmic domain of TMPRSS3, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
UniProt
P57727
Size
100ug
Cat. #
RP3TMPRSS3

In stock

SKU
RP-TMPRSS3

Options

As low as: $130.00

Target Overview

TMPRSS3 (Transmembrane protease serine 3, EC 3.4.21.-, UniProt P57727) is a type II transmembrane serine protease localized to the endoplasmic reticulum membrane. The 454-amino acid protein is expressed predominantly in the inner ear, where it functions as a permissive factor for cochlear and saccular hair cell survival and activation at the onset of hearing. TMPRSS3 belongs to the TMPRSS family of proteases, which also includes TMPRSS2 and TMPRSS4, and shares the characteristic modular architecture of a cytoplasmic domain, transmembrane segment, and extracellular catalytic domain. In vitro studies demonstrate that TMPRSS3 activates the epithelial sodium channel (ENaC), suggesting a role in ion homeostasis. Mutations in the TMPRSS3 gene are associated with autosomal recessive nonsyndromic hearing loss (DFNB8/DFNB10), making this protease a focal point for auditory research and genetic diagnosis of congenital deafness. Three rabbit polyclonal clones targeting the cytoplasmic domain are available from Triple Point Biologics, validated for detection in human samples with predicted cross-reactivity in mouse, rat, primate, and canine tissues.

Background

TMPRSS3 plays a critical role in auditory function, particularly in the maintenance and maturation of cochlear hair cells. Recent work has clarified its expression profile within the inner ear: Arora et al. (2025) demonstrated that Tmprss3 is expressed in multiple inner ear cell types, including type II spiral ganglion neurons, but is largely absent from type I neurons. This cell-type-specific expression pattern suggests a nuanced role in auditory signal processing and hair cell physiology. Mechanistically, Shearer et al. (2025) showed that the endocochlear potential contributes directly to hair cell death in TMPRSS3-related hearing loss, providing insight into the pathophysiology of DFNB8/DFNB10 and potential therapeutic targets.

From a clinical genetics perspective, TMPRSS3 mutations are a significant contributor to prelingual sensorineural hearing loss across diverse populations. Damrongchietanon et al. (2025) reported diagnostic yields from whole exome sequencing in Thailand, while Lim et al. (2026) characterized the mutational landscape of nonsyndromic hearing loss in Singapore, underscoring the global relevance of TMPRSS3 as a genetic biomarker. The protease is typically inactive until proteolytic cleavage releases the catalytic domain, and its substrates beyond ENaC remain poorly defined. Understanding TMPRSS3 substrate specificity and tissue-specific regulation is an active area of investigation, particularly in auditory neuroscience and ion channel biology.

Triple Point Biologics has supplied TMPRSS3 antibodies since 1994, with three polyclonal clones directed against the cytoplasmic domain. These reagents have been validated for Western blot in human tissues and are predicted to cross-react with mouse, rat, primate, and dog orthologs based on sequence homology.

References

  1. Arora R et al (2025) Tmprss3 is expressed in several cell types of the inner ear including type II but hardly in type I spiral ganglion neurons. Front Cell Neurosci. PubMed · 10.3389/fncel.2025.1690227
  2. Shearer AE et al (2025) Endocochlear potential contributes to hair cell death in TMPRSS3 hearing loss. J Clin Invest. PubMed · 10.1172/JCI186395
  3. Damrongchietanon T et al (2025) Diagnostic yield of whole exome sequencing with targeted gene analysis in prelingual sensorineural hearing loss in Thailand. Sci Rep. PubMed · 10.1038/s41598-025-18038-2
  4. Lim CK et al (2026) Genomic Biomarkers and Mutational Landscape of Nonsyndromic Hearing Loss (NSHL) in the Singaporean Population: Clinical Translational Implications. Biomolecules. PubMed · 10.3390/biom16030352

Additional Specifications

Gene Symbol TMPRSS3
UniProt ID P57727
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Cytoplasmic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-48.
Immunogen (SRCR domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 109-205.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 217-449.
Alternate Names TMPRSS3, Transmembrane protease serine 3, Serine protease TADG-12, Tumor-associated differentially-expressed gene 12 protein, TADG-12, EC 3.4.21.-

Frequently Asked Questions

What molecular weight should I expect for TMPRSS3 on a Western blot?

TMPRSS3 migrates at approximately 50-54 kDa on SDS-PAGE, corresponding to the full-length 454-amino acid type II transmembrane protease. The predicted molecular weight is around 49 kDa, but glycosylation of the extracellular catalytic domain can shift the apparent size upward. If you observe multiple bands, consider that TMPRSS3 may undergo proteolytic processing or post-translational modification in some cell types. We recommend including a lysate from inner ear tissue or a TMPRSS3-transfected cell line as a positive control to confirm the expected band pattern in your system.

What starting dilution do you recommend for Western blot with this TMPRSS3 antibody?

We validate this rabbit polyclonal at 1:1000 for Western blot. This is a reasonable starting point for most applications, but optimal dilution depends on your sample's TMPRSS3 expression level and your detection system sensitivity. Inner ear tissue and certain epithelial cell lines express TMPRSS3 endogenously; for low-abundance samples, you may need to increase antibody concentration to 1:500 or enrich membrane fractions. For overexpression systems, 1:2000 often provides clean signal without excessive background. Titrate against your lysate and detection method to find the best working dilution for your experiment.

Is this TMPRSS3 antibody likely to cross-react with TMPRSS2 or TMPRSS4?

TMPRSS family members share structural similarity, particularly within the serine protease catalytic domain, so cross-reactivity is a legitimate concern. This antibody was raised against a region spanning residues in the TMPRSS3 sequence, but we have not systematically tested cross-reactivity with TMPRSS2 or TMPRSS4. If you work with samples expressing multiple TMPRSS isoforms, include lysates from cells or tissues known to express only one family member, or use siRNA knockdown controls to confirm band identity. TMPRSS2 migrates at approximately 50-54 kDa and TMPRSS4 at 45-50 kDa, so molecular weight alone may not distinguish them.

Will this antibody recognize mouse and rat TMPRSS3 for Western blot?

This antibody is validated in human samples and predicted to recognize mouse and rat TMPRSS3 based on sequence homology in the immunogen region. However, we have not experimentally confirmed reactivity in rodent lysates. Human and mouse TMPRSS3 share approximately 80-85 percent sequence identity, so cross-species recognition is plausible but not guaranteed. If you plan to work with mouse or rat cochlear tissue or cell lines, we recommend running a small-scale pilot with a known positive control—such as inner ear lysate or a transfected cell line—to verify signal before committing to a full experiment.

What sample preparation works best for detecting endogenous TMPRSS3 by Western blot?

TMPRSS3 is a type II transmembrane protein anchored in the endoplasmic reticulum membrane, so membrane enrichment improves detection sensitivity. Whole-cell lysates work for high-expressing samples, but for low-abundance systems consider subcellular fractionation to isolate the membrane compartment. Use a lysis buffer containing 1 percent Triton X-100 or NP-40 to solubilize membrane proteins effectively; avoid SDS-only buffers during extraction, as they can aggregate transmembrane proteins. Include protease inhibitors to prevent degradation. Inner ear tissue, renal epithelium, and certain cancer cell lines express TMPRSS3 endogenously and serve as useful positive controls.

Does TMPRSS3 have isoforms or splice variants I should be aware of?

The primary TMPRSS3 transcript encodes the canonical 454-amino acid isoform, but alternative splicing has been reported in some tissues, particularly in the context of certain mutations linked to hereditary hearing loss. These variants may lack portions of the catalytic domain or transmembrane region, resulting in nonfunctional or secreted forms. On a Western blot, you may occasionally observe additional bands below 50 kDa if splice variants or proteolytic cleavage products are present. If you suspect isoform expression, confirm band identity with peptide competition or mass spectrometry, especially when working with patient-derived samples or genetically diverse model systems.

How should I store this TMPRSS3 antibody to maintain stability?

Store the antibody at -20°C for long-term stability. Avoid repeated freeze-thaw cycles, which can reduce titre and increase aggregation; aliquot upon receipt if you plan to use the antibody over several months. For short-term use, a working aliquot can be kept at 4°C for up to one month. Do not store diluted antibody in blocking buffer for more than a few days, as bacterial contamination and protein degradation become issues. If you observe declining signal over time, compare a fresh aliquot to your working stock to determine whether antibody degradation is the cause.

What controls should I include when using this TMPRSS3 antibody for the first time?

Include a positive control known to express TMPRSS3, such as inner ear tissue lysate, renal epithelial cells, or a transfected cell line overexpressing TMPRSS3. A negative control—such as lysate from a TMPRSS3 knockout cell line or a tissue with negligible expression—helps distinguish specific signal from background. If knockout material is unavailable, preincubate the antibody with the immunizing peptide to confirm that the signal is peptide-blockable. Run a no-primary-antibody control to assess secondary antibody background. These controls establish specificity and inform your interpretation of bands in experimental samples.

Western blot validation for RP-TMPRSS3 — 3 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

TMPRSS-3: Cytoplasmic domain — WB validation
WB · Panel 1 TMPRSS-3: Cytoplasmic domain
TMPRSS-3: SRCR domain — WB validation
WB · Panel 2 TMPRSS-3: SRCR domain
TMPRSS-3: Catalytic domain — WB validation
WB · Panel 3 TMPRSS-3: Catalytic domain

Custom validation studies available on request — contact us.

Also known as:

  • TMPRSS3
  • Transmembrane protease serine 3
  • Serine protease TADG-12
  • Tumor-associated differentially-expressed gene 12 protein
  • TADG-12
  • EC 3.4.21.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →